About Cardiac Insight
Cardiac Insight, Inc. is a privately held medical device company based in Bellevue, Washington, renowned for its innovative cardiac diagnostic products. Founded by Dr. Dave Hadley and Dr. Vic Froelicher, the company has been providing cardiac evaluations since launching its first product in 2013. The company's flagship products include the Cardea 20/20, a handheld 12-lead ECG device that enhances electrocardiogram reliability for detecting cardiovascular issues in young athletes with the industry's lowest false-positive rate of approximately 2%, and the Cardea SOLO, introduced in 2017, a comfortable 7-day wearable ambulatory sensor with software-assisted ECG analysis. The Cardea SOLO system enables patients to record their ECG from home while providing fast, in-office software analytics that generate reports in under five minutes. In 2021, Cardiac Insight joined forces with global electronic components leader DreamTech, solidifying their position as a leading innovator in cardiac healthcare diagnostics. The company is committed to advancing sensor and algorithm development that prioritizes accuracy in analyzing high-quality ECG data, with a focus on making ECG analysis more accessible for healthcare providers and patients through streamlined efficiency, client-centric focus, and continuous innovation.
Mission & Story
Mission
At the heart of Cardiac Insight is a commitment to advancing the development of sensors and algorithms that prioritize accuracy in analyzing high-quality ECG data—a pivotal element in our mission to save lives.
Founding Story
Pioneered by Dr. Dave Hadley and Dr. Vic Froelicher. Dr. Hadley's journey began with a Ph.D. at Caltech and co-founding Sierra Geophysics, working in seismic wave analysis before transitioning to software and joining Quinton Cardiology. In collaboration with Dr. Victor Froelicher, Dr. Hadley brought momentum to modern ECG analysis by shaping the 'Stanford Criteria' and developing the life-saving Cardea 20/20.
Clinical Focus
Medical conditions and clinical areas addressed by Cardiac Insight.
Who It Serves
Milestones & Awards
Recent Milestones
2021 partnership with DreamTech to solidify position as leading innovator in cardiac healthcare diagnostics
Key Partnerships
Company Details
- Founded
- 2013
- Headquarters
- Bellevue, WA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.